Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on September 4, 2026

Sep. 4, 2026

Alumis to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 4, 2026

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Indeterminate GlobeNewswire

Sep. 4, 2026

Kaplan Fox Alerts Planet Fitness, Inc. (NYSE: PLNT) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 14, 2026

Indeterminate GlobeNewswire

Sep. 4, 2026

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Indeterminate GlobeNewswire

Sep. 4, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 4, 2026

Glass House Brands to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 4, 2026

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Sep. 4, 2026

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 4, 2026

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Indeterminate GlobeNewswire

Sep. 4, 2026

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

Indeterminate GlobeNewswire

Sep. 4, 2026

PLNT Stock Drop: Planet Fitness Faces Securities Fraud Class Action Over Low Membership Growth; BFA Law Reminds Investors of September 14 Deadline

Indeterminate GlobeNewswire

Sep. 4, 2026

INVESTOR NOTICE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Indeterminate GlobeNewswire

Sep. 4, 2026

Immuron to launch PROIBS® in the United States

Indeterminate GlobeNewswire

Sep. 4, 2026

De Cape Town à Québec : Le passage du flambeau vers Safety 2028 est officiellement lancé

Indeterminate GlobeNewswire

Sep. 4, 2026

From Cape Town to Québec City: The Handover to Safety 2028 is Officially Underway

Indeterminate GlobeNewswire

Sep. 4, 2026

Raeliva Announces Rebrand and Expansion of Online Wellness Platform Beyond GLP-1 Care

Indeterminate GlobeNewswire

Sep. 4, 2026

Turlov Asks FIDE to Remove Candidate Wadim Rosenstein From the Ballot Over Sponsorship Deal With the German Chess Federation

Indeterminate GlobeNewswire

Sep. 4, 2026

Tangram Therapeutics gibt den Übergang zur Patientenkohortenphase in der Phase-I/II-Studie „RESTORE-MASH“ mit TGM-312 sowie die Ernennung von Dr. Sonya Montgomery zur Chief Development Officer bekannt

Indeterminate GlobeNewswire

Sep. 4, 2026

Tangram Therapeutics annonce le passage aux cohortes de patients dans l’essai de phase 1/2 RESTORE-MASH évaluant le TGM-312 et la nomination du Dr Sonya Montgomery au poste de directrice du développement

Indeterminate GlobeNewswire

Sep. 4, 2026

Persica Pharmaceuticals publishes new analyses of antibiotic exposure-response, reinforcing the scientific case for PP353 in vertebrogenic Lumbar Back Pain

Indeterminate GlobeNewswire